Systems Biology Approach for Personalized Hemostasis Correction

Area of Science:

• Biophysics
• Computational Biology
• Pharmacology

Background:

• Standard protocols for managing bleeding or thrombotic disorders using drugs like low-molecular-weight heparin (LMWH) may not be effective for all patients.
• Personalized therapy adjustment is crucial, but traditional laboratory hemostasis tests are costly and time-consuming.

Purpose of the Study:

• To develop a computational method for defining individual hemostasis profiles.
• To estimate the anticoagulant efficacy of LMWH using computer simulations of global hemostasis assays.
• To create a personalized pharmacokinetic model for LMWH integrated with a blood coagulation model.

Main Methods:

• Enrolled 12 patients on LMWH therapy, collecting blood samples at 3, 6, and 12 hours post-administration.
• Performed routine coagulation assays (aPTT, PT) and global hemostasis assays (thrombodynamics, thrombodynamics-4d).
• Measured anti-Xa activity, fibrinogen, prothrombin, antithrombin, creatinine clearance, lipid profiles, and blood counts.
• Developed a personalized LMWH pharmacokinetic model coupled with a mechanism-driven blood coagulation model.

Main Results:

• LMWH clearance was significantly lower in patients with high total cholesterol levels.
• Generated individual patient hemostasis profiles using routine coagulation assay results.
• Successfully simulated global hemostasis assay results based on individual patient responses to LMWH therapy.

Conclusions:

• Computer simulations can serve as an inexpensive and rapid alternative to laboratory tests for hemostasis assessment.
• The proposed method can potentially aid in adjusting hemostasis therapy based on simulated global test outputs.
• Personalized hemostasis profiling and simulation can improve the effectiveness of LMWH therapy.